Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Adamas Pharmaceuticals, Inc. (ADMS)

« Back to company index

ADMS Chatter Timeline

Stock Ticker for ADMS

Most Active Tweeters for ADMS

UserTweets
@otcdynamics 13
@Tickeron 9
@ZolmaxNews 8
@AmericanBanking 7
@ThisLincolnian 4

Recent Tweets for ADMS

InsiderAlertsIA @InsiderAlertsIA
$ADMS: New Insider Filing on Chief Financial Officer CHRISTOPHER B PRENTISS: https://t.co/4GepjyQX9z
5:01pm
otcdynamics @otcdynamics
$ADMS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, https://t.co/j7vaZcYrg0
5:01pm
MonitorAction @MonitorAction
$ADMS Christopher Prentiss Dumps 1.3K Shares of Adamas Pharmaceuticals Inc https://t.co/dLUowS9T9q
5:01pm
LargeVoidBot @LargeVoidBot
$ADMS Jan 21, CFO Sells 1269 Shrs; Net: -7.51k; Acq'd: 0; Disp'd: 1269 5.92/s https://t.co/Mpl4xc4vKC
5:01pm
insiderbuyings @insiderbuyings
$ADMS new insider selling: 1269 shares. https://t.co/tNSrUjZBXO
5:01pm
YMuer @YMuer
RT @otcdynamics: $ADMS Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas https://t.c…
11:01am
otcdynamics @otcdynamics
$ADMS Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas https://t.co/BVb861fFW3
11:01am
Endo1W @Endo1W
RT @TrendSpider: $ADMS Interesting :) https://t.co/rmqbq8IZMr
7:01am
Tickeron @Tickeron
$ADMS in Uptrend: Stochastic indicator is sitting in overbought zone for 10 days. View odds for this and other indi… https://t.co/UbqOxj7HGt
4:01am
TrendSpider @TrendSpider
$ADMS Interesting :) https://t.co/rmqbq8IZMr
12:01am
otcdynamics @otcdynamics
$ADMS Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baozun, https://t.co/mTwZu5mbt1
January 22nd 2020, 2:01pm
otcdynamics @otcdynamics
$ADMS INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and https://t.co/QR63pwGkmh
January 22nd 2020, 1:01pm
Tickeron @Tickeron
$ADMS's Aroon indicator drops into Downtrend on December 16, 2019. View odds for this and other indicators:… https://t.co/JwfrOJZhRF
January 21st 2020, 2:01am
TranscriptDaily @TranscriptDaily
Adamas Pharmaceuticals Inc $ADMS Receives Consensus Rating of “Hold” from Analysts https://t.co/rQLVW08ozK
January 20th 2020, 12:01pm
ZolmaxNews @ZolmaxNews
Analyzing Adamas Pharmaceuticals $ADMS and Zafgen $ZFGN https://t.co/k04807yw8A
January 20th 2020, 3:01am
Tickeron @Tickeron
$ADMS's Aroon indicator drops into Downtrend on December 16, 2019. View odds for this and other indicators:… https://t.co/jS8avx3hvp
January 20th 2020, 2:01am
Tickeron @Tickeron
$ADMS's Aroon indicator drops into Downtrend on December 16, 2019. View odds for this and other indicators:… https://t.co/4c8EsCdE9V
January 19th 2020, 3:01am
Tickeron @Tickeron
$ADMS's Aroon indicator drops into Downtrend on December 16, 2019. View odds for this and other indicators:… https://t.co/fcq7xwcVEJ
January 18th 2020, 3:01am
ZolmaxNews @ZolmaxNews
Kamada $KMDA versus Adamas Pharmaceuticals $ADMS Head to Head Analysis https://t.co/H0hGc0n28H
January 18th 2020, 2:01am
Tickeron @Tickeron
$ADMS's Aroon indicator drops into Downtrend on December 16, 2019. View odds for this and other indicators:… https://t.co/Uqzt1BLtpH
January 17th 2020, 3:01am
otcdynamics @otcdynamics
$ADMS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, https://t.co/MIkfXJ9vkp
January 17th 2020, 2:01am
otcdynamics @otcdynamics
$ADMS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, https://t.co/EiwO79gpWU
January 17th 2020, 12:01am
gcassidy718 @gcassidy718
$ADMS blockbuster 2.63 % change recently https://t.co/dvflrsAT2L
January 16th 2020, 7:01pm
StockNewsNow @StockNewsNow
$ADMS Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Phar… https://t.co/XLCgZ3Vur6
January 16th 2020, 5:01pm
Gambiste1 @Gambiste1
RT @Tdrag97: $ADMS there we go folks getting there https://t.co/eJvZ9ZMTsX
January 15th 2020, 4:01pm
otcdynamics @otcdynamics
$ADMS Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baozun, https://t.co/6shqRwTBBu
January 15th 2020, 4:01pm
gcassidy718 @gcassidy718
$ADMS price movement 4.04 % https://t.co/dvflrsAT2L
January 15th 2020, 4:01pm
Tdrag97 @Tdrag97
$ADMS there we go folks getting there https://t.co/eJvZ9ZMTsX
January 15th 2020, 4:01pm
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals Inc $ADMS Given Average Rating of “Hold” by Brokerages https://t.co/1v41D1EmAl #stocks
January 15th 2020, 1:01pm
dailypoliticaln @dailypoliticaln
Adamas Pharmaceuticals Inc $ADMS Receives Average Rating of “Hold” from Analysts https://t.co/DHT5uFNcUO
January 15th 2020, 12:01pm
bbnsnews @bbnsnews
Brokers Issue Forecasts for Adamas Pharmaceuticals Inc’s FY2019 Earnings $ADMS https://t.co/oEkRR1fsM0
January 15th 2020, 1:01am
ThisLincolnian @ThisLincolnian
William Blair Comments on Adamas Pharmaceuticals Inc’s FY2019 Earnings $ADMS https://t.co/PXpmWHWtQZ
January 15th 2020, 1:01am
EnterpriseLeade @EnterpriseLeade
Adamas Pharmaceuticals Inc Forecasted to Earn FY2019 Earnings of -$3.84 Per Share $ADMS https://t.co/Lu30d6G3k5
January 15th 2020, 1:01am
BlueBioNow @BlueBioNow
$ADMS major stock movement -2.51 % change recently https://t.co/XRyA8PlkjA
January 14th 2020, 9:01pm
otcdynamics @otcdynamics
$ADMS ROSEN, A LEADING LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline https://t.co/P3prGXTe7n
January 14th 2020, 4:01pm
Tickeron @Tickeron
$ADMS's Aroon indicator drops into Downtrend on December 16, 2019. View odds for this and other indicators:… https://t.co/T9dtJUaUrJ
January 14th 2020, 3:01am
bbnsnews @bbnsnews
Adamas Pharmaceuticals Inc Expected to Post FY2019 Earnings of -$3.84 Per Share $ADMS https://t.co/gLaqI7BA48
January 14th 2020, 1:01am
ZolmaxNews @ZolmaxNews
Svb Leerink Analysts Raise Earnings Estimates for Adamas Pharmaceuticals Inc $ADMS https://t.co/OmVtOhOhPD
January 14th 2020, 1:01am
TickerReport @TickerReport
FY2019 EPS Estimates for Adamas Pharmaceuticals Inc $ADMS Boosted by Svb Leerink https://t.co/wNT64omKLe
January 14th 2020, 1:01am
TickerReport @TickerReport
Adamas Pharmaceuticals Inc $ADMS Short Interest Update https://t.co/fjGi1m3K62
January 14th 2020, 1:01am
EnterpriseLeade @EnterpriseLeade
Adamas Pharmaceuticals Inc $ADMS Short Interest Update https://t.co/sV3ZxuTwJV
January 14th 2020, 1:01am
newsfilterio @newsfilterio
China rare earth exports rebound in December, but annual shipments lowest since 2015 $ADMS https://t.co/YDUEqBDUPR
January 14th 2020, 12:01am
ConsumerFeed @ConsumerFeed
Zacks: Analysts Anticipate Adamas Pharmaceuticals Inc $ADMS Will Announce Earnings of -$0.94 Per Share https://t.co/pss9LREFwz
January 13th 2020, 5:01pm
AmericanBanking @AmericanBanking
Head-To-Head Review: Zafgen $ZFGN vs. Adamas Pharmaceuticals $ADMS https://t.co/2Hqz7Ig6ho #stocks
January 13th 2020, 2:01pm
ConsumerFeed @ConsumerFeed
Head-To-Head Review: Adamas Pharmaceuticals $ADMS vs. Zafgen $ZFGN https://t.co/b76wRUS9Aa
January 13th 2020, 2:01pm
dispatchtribune @dispatchtribune
Analyzing Kamada $KMDA and Adamas Pharmaceuticals $ADMS https://t.co/cDDdkv62sc
January 13th 2020, 2:01pm
dailypoliticaln @dailypoliticaln
Head-To-Head Review: Zafgen $ZFGN vs. Adamas Pharmaceuticals $ADMS https://t.co/YMgaMQLXS3
January 13th 2020, 2:01pm
otcdynamics @otcdynamics
$ADMS INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and https://t.co/ZpPnBL1r6o
January 13th 2020, 1:01pm
gcassidy718 @gcassidy718
$ADMS major stock movement -6.49 % change recently https://t.co/dvflrsAT2L
January 13th 2020, 11:01am
otcdynamics @otcdynamics
$ADMS DEADLINE ALERT for HEXO, XYF, ADMS, EXC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on https://t.co/3esZ4mivgp
January 13th 2020, 11:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.